A Phase 1, Double-blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin®) Vaccine in Healthy US Adults.
Kao CM, Rostad CA, Nolan LE, Peters E, Kleinhenz J, Sherman JD, Tippett A, Shih JWK, Yildirim I, Agbakoba V, Beresnev T, Ballou C, Kamidani S, Karmali V, Natrajan M, Scherer EM, Rouphael N, Anderson EJ.
Kao CM, et al. Among authors: scherer em.
J Infect Dis. 2024 Mar 27:jiae148. doi: 10.1093/infdis/jiae148. Online ahead of print.
J Infect Dis. 2024.
PMID: 38536442